Sign In
CPSI Share                                                                  
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​​
Publication Type: Newsletter
Single or Multiple Incident: Multiple
Date: 10/9/2019 12:00:00 AM
Country: Canada

This newsletter discusses the similarities and differences between biologic medications and biosimilar medications. Biologics are made from living cells and can be very expensive to produce. Much like the generic versions of conventional medications, biosimilars are “near copies” that do the same job as the corresponding biologic medications, but they are typically more affordable. A biologic and its matching biosimilars will have the same common name, but the brand names will be different. It is important to know both the common name and the brand name, to avoid confusion when discussing the specific medication with a health care provider. This naming system may be confusing for consumers and for health care providers. The newsletter provides suggestions for consumers who are taking biologic medications to ensure they get and use the correct medication. These suggestions are available in the recommendations section of this alert.

Additional Details

etanercept (Enbrel®) etanercept (Brenzys®, Erelzi®)

Biologics and Biosimilars: What You Need to Know